Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5867 Articles

Douglas A. McIntyre | Jul 24, 2008 at 7:02 AM EDT

GE Makes a Health Care Acquisition (GE, VITL)

Vital Signs Inc. (NASDAQ: VITL) is going to gap way up this morning. The company is being acquired by General…

Douglas A. McIntyre | Jul 23, 2008 at 2:17 PM EDT

Genentech & Roche Merger Coming Under More Fire (DNA)

Genentech Inc. (NYSE: DNA) is running into some issues over the merger with Roche at $89.00 per share. Wall Street…

Douglas A. McIntyre | Jul 22, 2008 at 8:50 AM EDT

State Street International Health Care ETF Launch (STT, IRY)

State Street Corporation (NYSE: STT) has announced that its State Street Global Advisors unit is launching 10 new SPDR exchange-traded…

Douglas A. McIntyre | Jul 21, 2008 at 4:20 PM EDT

Merck Visits The Proctologist (MRK)

Merck & Co. (NYSE: MRK) posted earnings that look pretty good on the surface. The problem is that the surface…

Douglas A. McIntyre | Jul 16, 2008 at 7:42 AM EDT

ERBITUX Gets Approved in Japan for Colorectal Cancer (IMCL, BMY)

ImClone Systems Incorporated (NASDAQ: IMCL) has just announced that ERBITUX(R) has received marketing authorization in Japan for use in treating…

Douglas A. McIntyre | Jul 14, 2008 at 3:12 PM EDT

Genentech Masks a Whiff (DNA)

Genentech Inc. (NYSE: DNA) is initially looking like a severe disappointment to those who thought Cramer’s call last week was…

Douglas A. McIntyre | Jul 14, 2008 at 12:37 PM EDT

Genentech Ready to Lead Biotech Earnings Bias (DNA, BIIB)

Genentech Inc. (NYSE: DNA) is set to report earnings after the close of trading today. The largest biotech in the…

Douglas A. McIntyre | Jul 8, 2008 at 1:38 PM EDT

Long-Term Risks To Statin Sales? (MRK, PFE, AZN)

We have run a full feature story over at BioHealthInvestor.com after reading a study that came off the Mayo Clinic…

Douglas A. McIntyre | Jul 4, 2008 at 7:31 AM EDT

This Week’s BioHealth & Biotech Top Stories

We saw another exciting week full of news for key developments in drug stocks, biotech stocks, medical device stocks, and…

Douglas A. McIntyre | Jul 2, 2008 at 6:17 AM EDT

IPO FILING: ZONARE MEDICAL SYSTEMS (ZONE)

ZONARE MEDICAL SYSTEMS, INC. has filed for an initial public offering to sell up to $86.25 million as the nominal…

Douglas A. McIntyre | Jul 2, 2008 at 5:51 AM EDT

IPO FILING: Alimera Sciences, Inc. (ALIM)

A company called Alimera Sciences, Inc. has filed for an initial public offering to sell up to $75 million as…

Douglas A. McIntyre | Jul 2, 2008 at 5:26 AM EDT

UnitedHealth Guidance Tanks Again (UNH)

UnitedHealth Group (NYSE:UNH) is again lowering its guidance. The company now sees $2.95 to $3.05 EPS on revenues of around…

Douglas A. McIntyre | Jun 30, 2008 at 4:42 AM EDT

The Whining From Drug Companies: The FDA Is Hard On Us

The profit-mongering Big Pharma companies don’t want the FDA to take so long approving their drugs. It cuts into profits…

Douglas A. McIntyre | Jun 26, 2008 at 8:03 AM EDT

Sequenom Holds Up Well On Secondary Offering (SQNM)

Sequenom, Inc. (NASDAQ: SQNM) has priced its public secondary offering of 5,500,000 shares of common stock at a price of…

Douglas A. McIntyre | Jun 24, 2008 at 3:55 PM EDT

StemCells Shelf Filing Seems Almost ‘Re-IPO’ (STEM)

StemCells Inc. (NASDAQ: STEM) has filed a mixed securities shelf registration that will allow the company to raise up to…

1 … 349 350 351 352 353 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

GE Makes a Health Care Acquisition (GE, VITL)

Genentech & Roche Merger Coming Under More Fire (DNA)

State Street International Health Care ETF Launch (STT, IRY)

Merck Visits The Proctologist (MRK)

ERBITUX Gets Approved in Japan for Colorectal Cancer (IMCL, BMY)

Genentech Masks a Whiff (DNA)

Genentech Ready to Lead Biotech Earnings Bias (DNA, BIIB)

Long-Term Risks To Statin Sales? (MRK, PFE, AZN)

This Week’s BioHealth & Biotech Top Stories

IPO FILING: ZONARE MEDICAL SYSTEMS (ZONE)

IPO FILING: Alimera Sciences, Inc. (ALIM)

UnitedHealth Guidance Tanks Again (UNH)

The Whining From Drug Companies: The FDA Is Hard On Us

Sequenom Holds Up Well On Secondary Offering (SQNM)

StemCells Shelf Filing Seems Almost ‘Re-IPO’ (STEM)

Here’s What a $500,000 Budget Actually Buys You in Naples, Florida

Dave Ramsey to a Debt-Free 50-Year-Old Who Left a $105K Job to Train Clients: You’re a Gym Rat That Gets Paid Sometimes

He Reached His Medicare Advantage Plan’s Out-of-Pocket Maximum. His Pharmacy Bills Kept Coming.

Here's What a $500,000 Budget Actually Buys You in Naples, Florida

Dave Ramsey to a Debt-Free 50-Year-Old Who Left a $105K Job to Train Clients: You're a Gym Rat That Gets Paid Sometimes

$10,000 in XRP vs $10,000 in HYPE: Which Is Worth More by 2030?

Here’s What a $500,000 Budget Actually Buys You in Naples, Florida

Health and Healthcare Articles

All Health and Healthcare Articles

GE Makes a Health Care Acquisition (GE, VITL)

Genentech & Roche Merger Coming Under More Fire (DNA)

State Street International Health Care ETF Launch (STT, IRY)

Merck Visits The Proctologist (MRK)

ERBITUX Gets Approved in Japan for Colorectal Cancer (IMCL, BMY)

Genentech Masks a Whiff (DNA)

Genentech Ready to Lead Biotech Earnings Bias (DNA, BIIB)

Long-Term Risks To Statin Sales? (MRK, PFE, AZN)

This Week’s BioHealth & Biotech Top Stories

IPO FILING: ZONARE MEDICAL SYSTEMS (ZONE)

IPO FILING: Alimera Sciences, Inc. (ALIM)

UnitedHealth Guidance Tanks Again (UNH)

The Whining From Drug Companies: The FDA Is Hard On Us

Sequenom Holds Up Well On Secondary Offering (SQNM)

StemCells Shelf Filing Seems Almost ‘Re-IPO’ (STEM)

Here’s What a $500,000 Budget Actually Buys You in Naples, Florida

Dave Ramsey to a Debt-Free 50-Year-Old Who Left a $105K Job to Train Clients: You’re a Gym Rat That Gets Paid Sometimes

He Reached His Medicare Advantage Plan’s Out-of-Pocket Maximum. His Pharmacy Bills Kept Coming.

Featured Reads

Here's What a $500,000 Budget Actually Buys You in Naples, Florida

Dave Ramsey to a Debt-Free 50-Year-Old Who Left a $105K Job to Train Clients: You're a Gym Rat That Gets Paid Sometimes